 |
 |

Are the Catabolic Effects of Tumor Necrosis Factor Mediated by Glucocorticoids?
Kenneth Mealy, FRCSI;
Joseph J. B. van Lanschot, MD;
Bruce G. Robinson, MD;
Jan Rounds;
Douglas W. Wilmore, MD
Arch Surg. 1990;125(1):42-48.
Abstract
 |  |
The effect of tumor necrosis factor (TNF) on the hypothalamic-adrenal stress response was determined by infusion of TNF, 0, 2x105, and 4x 105 U/kg per 24 hours, in parenterally fed male Wistar rats. Following infusions over 1 to 6 days, adrenal weight was increased with increasing dosage of TNF. Tumor necrosis factor at a dosage of 4x 105 U/kg per 24 hours increased the plasma corticotropin level over the same period. In a further series of experiments the metabolic effects of TNF were compared with the effects of corticosterone, the predominant glucocorticoid in the rat. In comparison with controls, rats given corticosterone (75 mg subcutaneously) or TNF (2x 105 U/kg per 24 hours) demonstrated decreased nitrogen balance and diminished carcass nitrogen content over a 6-day period. Tumor necrosis factor alone, however, induced a significant increase in liver nitrogen content and diminished jejunal mucosa DNA and protein levels in comparison with the control and corticosterone groups. Finally, adrenalectomized animals receiving basal corticosterone replacement were infused with TNF. Urinary nitrogen loss was significantly diminished in these animals compared with sham adrenalectomized controls, indicating that an intact adrenal stress response is necessary for the increased nitrogen loss following TNF infusion. Tumor necrosis factor may exert an important regulatory influence on the interorgan substrate flux that occurs during critical illness. The effects of TNF on skeletal muscle proteolysis can be simulated by adrenal glucocorticoid administration. The effects of this cytokine on visceral organs appear to be unique to TNF and cannot be reproduced by the administration of glucocorticoids alone.
(Arch Surg. 1990;125:42-48)
Author Affiliations
From the Departments of Surgery (Drs Mealy, van Lanschot, and Wilmore and Ms Rounds) and Medicine (Dr Robinson), Brigham and Woman's Hospital, Harvard Medical School, Boston, Mass.
Footnotes
Accepted for publication October 14, 1989.
Read before the Ninth Annual Meeting of the Surgical Infection Society, Denver, Colo, April 14, 1989.
Reprint requests to Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115 (Dr Wilmore).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Acute Moderate Elevation of TNF-{alpha} Does Not Affect Systemic and Skeletal Muscle Protein Turnover in Healthy Humans
Petersen et al.
J. Clin. Endocrinol. Metab. 2009;94:294-299.
ABSTRACT
| FULL TEXT
Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle
Sun et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002;282:R509-R518.
ABSTRACT
| FULL TEXT
Effect of fentanyl on morphine levels in the brain in rats receiving intracerebroventricular injection of TNF-alpha
Shirouzu et al.
Am. J. Physiol. Endocrinol. Metab. 1998;275:E635-E640.
ABSTRACT
| FULL TEXT
Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-{kappa}B activation in response to tumor necrosis factor {alpha}
Li et al.
FASEB J. 1998;12:871-880.
ABSTRACT
| FULL TEXT
Review: The Role of Cytokines in the Catabolic Consequences of Infection and Injury
Chang and Bistrian
JPEN J Parenter Enteral Nutr 1998;22:156-166.
ABSTRACT
Invited Review: Cytokine Mediators of Malnutrition: Clinical Implications
Hardin
Nutr Clin Pract 1993;8:55-59.
ABSTRACT
The Hypothalamic-Pituitary-Adrenal--Immune Axis: A Critical Assessment
Lilly and Gann
Arch Surg 1992;127:1463-1474.
ABSTRACT
Evidence That Tumor Necrosis Factor Participates in the Regulation of Muscle Proteolysis During Sepsis
Zamir et al.
Arch Surg 1992;127:170-174.
ABSTRACT
TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation
Lang et al.
Am. J. Physiol. Endocrinol. Metab. 2002;282:E336-E347.
ABSTRACT
| FULL TEXT
|